Hemoglobinuria - 39 Studies Found

Recruiting : Phase 2 Safety and Efficacy Study of RA101495 to Treat PNH Patients Who Have an Inadequate Response to Eculizumab
: Paroxysmal Nocturnal Hemoglobinuria (PNH)
: 2017-01-20
: Drug: RA101495 0.3mg/kg subcutaneously (SC) at Day 1 (loading dose) followed by a starting maintenance d
Completed : Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease
:
  • Rheologic Disease
  • Sickle Cell Disease
  • Paroxysmal Nocturnal Hemoglobinuria
    : 2015-10-27
    : Drug: APL-2
Active, not recruiting : A Phase I Study to Assess the Safety APL-2 as an Add-On to Standard of Care in Subjects With PNH
: Paroxysmal Nocturnal Hemoglobinuria (PNH)
: 2014-10-08
: Drug: APL-2
Active, not recruiting : A Phase 1/2 Study of an Investigational Drug, ALN-CC5, in Healthy Adult Volunteers and Patients With PNH
: Paroxysmal Nocturnal Hemoglobinuria (PNH)
: 2015-01-23
:
  • Drug: ALN-CC5 Single or multip
Active, not recruiting : Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria
:
  • Paroxysmal Nocturnal Hemoglobinuria
  • Hemoglobinuria
  • : 2012-07-14
    :
    • Drug: Levamisole+cyclosporin A+Glucocorticoids